Artemis Medicare Services Limited is an India-based company. The Company manages and operates a multi-specialty hospital. It specializes in a range of advanced medical and surgical interventions, a mix of inpatient and outpatient services. It offers treatment facilities for various medical conditions under various specialties, which include allergy and immunology, blood (hematology), bones, muscles and joints (orthopedics), brain, spine and nervous system, cancer (oncology), circulatory (vascular), dermatology, digestive (gastroenterology), endocrine, diabetes and cardiology, infectious diseases, sleep apnea, kidneys stone treatment and failure (renal), lung (pulmonary), mouth, teeth and face (oral and maxillofacial), obstetrics and gynecology, psychiatry, arthritis and joint disease, surgery, and urology. It also offers treatment for irregular periods, vertigo, finger joint treatment, and piles. The Company's subsidiary includes Artemis Cardiac Care Private Limited.As of 25 May 2026, Artemis Med Service share price is ₹288.50. The stock opened at ₹284.65, compared to its previous close of ₹273.03. During today's trading session, Artemis Med Service share price moved in the range of ₹280.12 to ₹292.00, with an average price of ₹286.06 for the day. Looking at its last 52-week, the stock has touched a low of ₹280.12 and a high of ₹292.00. On the performance front, Artemis Med Service share price has declined by 0.06% over the last six months and is up 12.76% on a year-on-year basis.
The market capitalization of Artemis Med Service is ₹4,333 Crs, with a P/E ratio of 41.8 and a dividend yield of 0.16%.